Gui Q, Wang H, Liu C, Li W, Zhou B, Tang S
Virol J. 2025; 22(1):45.
PMID: 39994733
PMC: 11849304.
DOI: 10.1186/s12985-025-02667-0.
Tao T, Tian L, Ke J, Zhang C, Li M, Xu X
Int J Biol Sci. 2025; 21(4):1686-1704.
PMID: 39990674
PMC: 11844293.
DOI: 10.7150/ijbs.96112.
Eriksson M, Larsson A
Antibodies (Basel). 2025; 14(1).
PMID: 39982233
PMC: 11843883.
DOI: 10.3390/antib14010018.
Simpson J, Kasson P
PLoS Comput Biol. 2025; 21(2):e1012812.
PMID: 39908344
PMC: 11809852.
DOI: 10.1371/journal.pcbi.1012812.
Bdeir N, Luddecke T, Maass H, Schmelz S, Rand U, Jacobsen H
Nat Commun. 2025; 16(1):809.
PMID: 39827186
PMC: 11743207.
DOI: 10.1038/s41467-025-55871-5.
Ancestral SARS-CoV-2 immune imprinting persists on RBD but not NTD after sequential Omicron infections.
Wang Z, Li L, Du R, Chen X, Sun Y, Qin R
iScience. 2025; 28(1):111557.
PMID: 39807166
PMC: 11728909.
DOI: 10.1016/j.isci.2024.111557.
Development of a two-component recombinant vaccine for COVID-19.
Sun Y, Xu F, Zhu H, Xia Y, Li Q, Luo Y
Front Immunol. 2025; 15:1514226.
PMID: 39759508
PMC: 11695372.
DOI: 10.3389/fimmu.2024.1514226.
Structural Immunology of SARS-CoV-2.
Yuan M, Wilson I
Immunol Rev. 2024; 329(1):e13431.
PMID: 39731211
PMC: 11727448.
DOI: 10.1111/imr.13431.
Enhanced antibody response to the conformational non-RBD region DNA prime-protein boost elicits broad cross-neutralization against SARS-CoV-2 variants.
Ma Y, Chen K, Xie B, Zhu J, He X, Chen C
Emerg Microbes Infect. 2024; 14(1):2447615.
PMID: 39727342
PMC: 11878195.
DOI: 10.1080/22221751.2024.2447615.
Structural serology of polyclonal antibody responses to mRNA-1273 and NVX-CoV2373 COVID-19 vaccines.
Bangaru S, Jackson A, Copps J, Fernandez-Quintero M, Torres J, Richey S
bioRxiv. 2024; .
PMID: 39713412
PMC: 11661243.
DOI: 10.1101/2024.12.11.628030.
SARS-CoV-2 Omicron variations reveal mechanisms controlling cell entry dynamics and antibody neutralization.
Qing E, Salgado J, Wilcox A, Gallagher T
PLoS Pathog. 2024; 20(12):e1012757.
PMID: 39621785
PMC: 11637440.
DOI: 10.1371/journal.ppat.1012757.
Defining the features and structure of neutralizing antibody targeting the silent face of the SARS-CoV-2 spike N-terminal domain.
Zhang Z, Zhang Y, Cheng L, Zhang L, Yan Q, Liu X
MedComm (2020). 2024; 5(12):e70008.
PMID: 39619228
PMC: 11604724.
DOI: 10.1002/mco2.70008.
Benchmark Investigation of SARS-CoV-2 Mutants' Immune Escape with 2B04 Murine Antibody: A Step Towards Unraveling a Larger Picture.
Kapusta K, McGowan A, Banerjee S, Wang J, Kolodziejczyk W, Leszczynski J
Curr Issues Mol Biol. 2024; 46(11):12550-12573.
PMID: 39590339
PMC: 11592782.
DOI: 10.3390/cimb46110745.
Structural characterization of human monoclonal antibodies targeting uncommon antigenic sites on spike glycoprotein of SARS-CoV.
Suryadevara N, Kose N, Bangaru S, Binshtein E, Munt J, Martinez D
J Clin Invest. 2024; 135(3).
PMID: 39589795
PMC: 11785922.
DOI: 10.1172/JCI178880.
Viral N protein hijacks deaminase-containing RNA granules to enhance SARS-CoV-2 mutagenesis.
Li Z, Luo L, Ju X, Huang S, Lei L, Yu Y
EMBO J. 2024; 43(24):6444-6468.
PMID: 39567830
PMC: 11649915.
DOI: 10.1038/s44318-024-00314-y.
A human monoclonal antibody neutralizing SARS-CoV-2 Omicron variants containing the L452R mutation.
Stein S, Hansen G, Ssebyatika G, Stroh L, Ochulor O, Herold E
J Virol. 2024; 98(12):e0122324.
PMID: 39494911
PMC: 11650997.
DOI: 10.1128/jvi.01223-24.
Design of customized coronavirus receptors.
Liu P, Huang M, Guo H, McCallum M, Si J, Chen Y
Nature. 2024; 635(8040):978-986.
PMID: 39478224
DOI: 10.1038/s41586-024-08121-5.
Structural insight into broadening SARS-CoV-2 neutralization by an antibody cocktail harbouring both NTD and RBD potent antibodies.
Jiang W, Jiang Y, Sun H, Deng T, Yu K, Fang Q
Emerg Microbes Infect. 2024; 13(1):2406300.
PMID: 39470577
PMC: 11610255.
DOI: 10.1080/22221751.2024.2406300.
Advancements in the Development of Anti-SARS-CoV-2 Therapeutics.
Huang J, Ma Q, Su Z, Cheng X
Int J Mol Sci. 2024; 25(19).
PMID: 39409149
PMC: 11477007.
DOI: 10.3390/ijms251910820.
Broad-Spectrum Engineered Multivalent Nanobodies Against SARS-CoV-1/2.
Wang Z, Shi Z, Liao X, Quan G, Dong H, Zhao P
Adv Sci (Weinh). 2024; 11(45):e2402975.
PMID: 39373693
PMC: 11615778.
DOI: 10.1002/advs.202402975.